Results 21 to 30 of about 42,809 (327)

Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis

open access: yesHepatology, EarlyView., 2022
Phase 1b study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Abstract Background and Aims We evaluated the efficacy and safety of the antiangiogenic tyrosine kinase inhibitor anlotinib plus TQB2450, a programmed death‐ligand 1 inhibitor in pretreated advanced biliary tract cancers (BTCs ...
Jun Zhou   +13 more
wiley   +1 more source

Variants of gallbladder adenocarcinomas: Five case reports

open access: yesSahel Medical Journal, 2016
Conventional adenocarcinomas comprise of about 90% of all gallbladder neoplasms; among them, pancreatobiliary is the most common phenotype followed by intestinal and gastric foveolar types.
Subhajit Das   +3 more
doaj   +1 more source

Surgical treatment of gallbladder polypoid lesions [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2003
INTRODUCTION Polypoid lesions of the gallbladder can be divided into benign and malignant categories. Malignant polypoid lesions include carcinomas of the gallbladder, which is the fifth most common malignancy of the gastrointestinal tract and the most ...
Pejić Miljko A., Milić Dragan J.
doaj   +1 more source

Clinicopathologic significance of the delta-like ligand 4, vascular endothelial growth factor, and hypoxia-inducible factor-2α in gallbladder cancer [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2023
Background Gallbladder cancer (GBC) is usually detected in advanced stages with a low 5-year survival rate. Delta-like ligand 4 (DLL4), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-2alpha (HIF2α) have been studied for their ...
Sujin Park   +4 more
doaj   +1 more source

Laparoscopic approach to well-differentiated adenocarcinoma of the gallbladder in a dog: a novel case report [PDF]

open access: yesCiência Rural
: Primary gallbladder neoplasms are rare in dogs, and the treatment of choice is surgical resection. This report addresses the case of a dog with well-differentiated adenocarcinoma of the gallbladder that underwent laparoscopic cholecystectomy, an ...
Franciéli Mallmann Pozzobon   +9 more
doaj   +1 more source

Liver: Intrahepatic cholangiocarcinoma [PDF]

open access: yes, 2009
Review on Liver: Intrahepatic cholangiocarcinoma, with data on clinics, and the genes ...
Aishima, S, Enjoji, M
core   +1 more source

Adenoma of the gallbladder in a mongoose (Mungos mungo)

open access: yesCiência Rural, 2016
: Primary gallbladder neoplasms occur infrequently in domestic animals and rarely in wild animals. This article describes a case of gallbladder adenoma in a mongoose ( Mungos mungo) in captivity.
Saulo Pereira Cardoso   +5 more
doaj   +1 more source

Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas [PDF]

open access: yes, 2019
The bile duct system and pancreas show many similarities due to their anatomical proximity and common embryological origin. Consequently, preneoplastic and neoplastic lesions of the bile duct and pancreas share analogies in terms of molecular ...
Alvaro, D   +10 more
core   +1 more source

Bifocal intracholecystic tubulopapillary neoplasm: A rare and distinct tumor of the gallbladder

open access: yesClinical Case Reports, 2022
Intracholecystic papillary‐tubular neoplasms are rare precancerous and polypoid lesions of the gallbladder, found in nearly 0.4% of cholecystectomy specimens. They follow the adenoma‐carcinoma sequence.
Faten Limaiem   +3 more
doaj   +1 more source

Value of Ascitic Lipids in the Differentiation between Cirrhotic and Malignant Ascites [PDF]

open access: yes, 1986
Ascitic fluid concentrations of cholesterol, triglycerides and phospholipids, were compared with ascitic fluid total protein in 40 patients with chronic liver disease, 51patients with various neoplasms and 1 patient with cardiac failure.
Alexander L. Gerbes   +22 more
core   +1 more source

Home - About - Disclaimer - Privacy